Gastrointestinal peptide secretion

Gastrointestinal peptide secretion refers to the collective process by which various peptide hormones are secreted from specialized cells in the gastrointestinal (GI) tract. These peptides include gastrin, cholecystokinin (CCK), secretin, gastric inhibitory peptide (GIP), glucagon-like peptide 1 (GLP-1), vasoactive intestinal peptide (VIP), and others. Each of these peptides has its own specific molecular identity and function. Gastrointestinal peptide secretion refers broadly to the regulated release of numerous biologically active peptides from specialized enteroendocrine cells distributed throughout the gastrointestinal tract mucosa. These cells respond to diverse stimuli—including nutrients like glucose, amino acids, fatty acids; mechanical distension; neural signals—to secrete hormones such as gastrin, CCK, secretin, GIP, GLP‑1, VIP and others. Each hormone acts through its own receptor(s) on various cell types within the digestive system and beyond—modulating acid production by parietal cells, pancreatic enzyme/bicarbonate output, smooth muscle contraction/relaxation, insulin/glucaogn release from pancreatic islets, among other effects. Dysregulation can contribute to diseases ranging from peptic ulcers and malabsorption syndromes to metabolic disorders like type 2 diabetes mellitus. This term should not be treated as an individual drug target but rather recognized as an umbrella term encompassing many distinct targets—each requiring separate structured entries if detailed pharmacological information is needed.

Other names

GI hormone releaseEnteroendocrine hormone secretionGut hormone secretion

Mechanisms depend on the specific hormone/receptor targeted; examples include agonism/antagonism at GPCRs for gut peptides. Individual mechanisms include stimulation/inhibition of release from enteroendocrine cells.